Current Trends in Venture Capital • 12/06/2025 Exploring the Role of Venture Capital in the Tech Industry
Current Trends in Venture Capital • 12/06/2025 Strategic Insights from Columbia Pacific Advisors in Seattle
Current Trends in Venture Capital • 03/06/2026 The dry powder paradox: why $300B deployed in Q1 doesn't mean the market is loose A deep dive into how venture capital dry powder will be deployed in 2026, from AI mega rounds and barbell dynamics to fund construction, reserve strategies, and a practical career playbook for aspiring VCs.
Emerging Technologies and Markets • 18/05/2026 Isomorphic Labs raises $2.1B: what the largest AI drug discovery round tells allocators about biotech's next chapter Analysis of Isomorphic Labs’ reported $2.1B Series B, what it signals for AI drug discovery venture capital funding, and how allocators should rethink risk, portfolio construction and sovereign capital in AI native biopharmaceutical platforms.
Current Trends in Venture Capital • 15/05/2026 Buy over build: why large corporates are paying venture premiums in 2026 Learn how a corporate buy over build M&A strategy helps CEOs accelerate innovation, justify strategic premiums, and turn corporate development into a repeatable growth engine while managing regulatory risk.
Current Trends in Venture Capital • 14/05/2026 Mid-year VC trends review: the thesis shifts founders should already be pricing in Mid-year venture capital trends in 2024: how AI megadeals, sector rotation, LP allocation shifts, and a higher cost of capital are reshaping deal pacing, term sheets, and summer fundraising strategy for CEOs.
Current Trends in Venture Capital • 13/05/2026 The IPO window is cracking open: what corp dev teams should price in How the 2026 IPO–M&A window reshapes corporate development: reserve price math, valuation discipline, global comps and board-level playbooks for CEOs competing with private equity and public markets.
Current Trends in Venture Capital • 06/05/2026 Biotech venture in 2026: why the $600M rounds are not a bubble Biotech venture capital trends can look frothy, but late-stage mega rounds are really structured options on clinical trials and pharma M&A. Learn how Phase 2 costs, pharma acquirers, platform versus program bets, and geopolitics shape biotech valuations for CEOs and generalist VCs. by Eloise Adler
Types of Venture Funds • 04/05/2026 Lockheed Martin Ventures doubles to $1B: the corporate venture playbook gets a $600M upgrade Lockheed Martin’s 1B fund signals a new era for corporate venture capital in defense, with CVCs competing on terms, dual-use theses, and board-level strategic impact. by Leonardo Agostini
Current Trends in Venture Capital • 24/04/2026 Founders, read the megadeal math: what concentrated AI funding actually does to your round AI funding concentration is reshaping venture capital. Learn how LP reallocation, mega-rounds, and changing acquirer behavior affect follow-on capital, board expectations, and exit math—and what founders can do to keep negotiating power. by Leonardo Agostini
Current Trends in Venture Capital • 21/04/2026 Q1 2026 funding roundup: the deals, funds, and valuations that reset the benchmarks Detailed Q1 2026 VC funding roundup for CEOs, covering valuations, round sizes, AI and infrastructure trends, sector shifts, exits, and M&A signals across global venture capital markets. by Tanisha Patel
Current Trends in Venture Capital • 20/04/2026 Four rounds, 65% of global VC: what the Q1 2026 mega-round concentration means for your thesis Analysis of Q1 2026 venture capital mega rounds: how 188B dollars in AI-focused financings reshaped global VC allocation, LP behavior, and CEO fundraising strategy outside the frontier lab oligopoly. by Elias Raphael
Current Trends in Venture Capital • 13/03/2026 How cambridge angels and dogtooth technologies signal a new era for agricultural robotics strategy How the cambridge angels and dogtooth technologies partnership reshapes agricultural robotics strategy, funding, and competitive positioning for CEOs in tech intensive sectors. by Tanisha Patel
Current Trends in Venture Capital • 03/03/2026 Premium mergers and acquisitions services for buyers seeking strategic advantage Strategic guide for CEOs on premium mergers and acquisitions services for buyers, aligning investment, capital, and portfolio decisions to maximize long term value. by Tanisha Patel
Current Trends in Venture Capital • 25/02/2026 Fund administration news that actually matters for your strategy Fund administration news is reshaping how CEOs think about control, risk, and growth. Learn which shifts in fund administration really matter for your company strategy and how to respond. by Leonardo Agostini
Current Trends in Venture Capital • 29/01/2026 What CEOs need to know from private equity news today in October Stay updated on the latest private equity news today in October. Explore strategic insights and trends relevant for CEOs navigating company strategy in a changing market. by Otis Blackwood
Current Trends in Venture Capital • 25/12/2025 How steelsky ventures emerged as a strategic leader in venture capital Explore how steelsky ventures, founded 2017, became a strategic leader in venture capital by mastering adaptability, fostering innovation, and building resilient partnerships. Insights tailored for CEOs navigating company strategy. by Isabella Fiorentino
Early-Stage vs. Late-Stage Investing • 24/12/2025 How the power law shapes venture capital portfolio size decisions Explore the implications of power law on venture capital portfolio size and how CEOs can leverage this understanding to refine company strategy and investment approaches. by Ava Henderson
Current Trends in Venture Capital • 22/12/2025 How johnson-adams associates funding shapes strategic decisions for CEOs Explore how johnson-adams associates funding influences company strategy and decision-making for CEOs, with insights on capital allocation, risk management, and long-term growth. by Harold McBride
Current Trends in Venture Capital • 21/12/2025 How PittMoss leveraged Shark Tank to transform its business strategy Explore how PittMoss used its Shark Tank appearance to reshape its company strategy, offering valuable lessons for CEOs navigating growth and innovation. by Isabella Fiorentino
Emerging Technologies and Markets • 18/12/2025 Understanding the strategic implications of altos labs stock for CEOs Explore how altos labs stock influences company strategy from a CEO's perspective. Learn about market positioning, investor expectations, and long-term planning in the biotech sector. by Elias Raphael
Emerging Technologies and Markets • 12/12/2025 How fintechzoom com bonds are reshaping corporate finance strategy Explore how fintechzoom com bonds influence company strategy, offering CEOs new approaches to corporate finance, risk management, and growth opportunities. by Elias Raphael
